PPHM Financial Facts
Cost of contract manufacturing: 3.65MResearch and development: 5.44M
See Full Income Statement
Total stockholders’ equity: 17.4M
Other current liabilities: 930K
See Full Balance Sheet
Earnings History for Peregrine Pharmaceuticals Inc. (PPHM)
|
Expand Research on PPHM
| Next EPS Date | 4/12/13 *Est. | EPS Growth Rate | +69.2% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +28.4% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +11.3% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
9/10/12  |
Q113 | -$0.07 | -$0.11 | +$0.04 | $4.25M | $3.97M | N/A / N/A | N/A | -59.3% | Details | |
| 3/11/11 |
 |
Q311 | -$0.14 | -$0.11 | -$0.03 | $2.88M | $5.26M | N/A / N/A | N/A | -22.5% | Details |
| 7/14/11 |
|
Q211 | -$0.15 | -$0.15 | $0.00 | $2.83M | $2.28M | N/A / N/A | N/A | -13.7% | Details |
| 3/9/12 |
|
Q312 | -$0.13 | -$0.13 | $0.00 | $3.28M | $2.12M | N/A / N/A | N/A | 0% | Details |
| 3/12/13 |
|
Q313 | -$0.04 | -$0.07 | +$0.03 | N/A | $3.9M | N/A / N/A | N/A | +15.8% | Details |
| 9/9/11 |
|
Q112 | -$0.11 | -$0.15 | +$0.04 | $5.66M | $2.17M | N/A / N/A | N/A | +44.1% | Details |
| 12/10/12 |
|
Q213 | -$0.08 | -$0.09 | +$0.01 | $6.14M | $4.03M | N/A / N/A | N/A | +51.2% | Details |
| 12/12/11 |
|
Q212 | -$0.16 | -$0.14 | -$0.02 | $4.23M | $2.08M | N/A / N/A | N/A | +59.1% | Details |
